CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition | Xing | Folia Histochemica et Cytobiologica - Via Medica Journals
CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition | Xing | Folia Histochemica et Cytobiologica Via Medica Journals
Genetics of Endometriosis-Associated Ovarian Cancer: A Systematic Review.
Up to 1.6% of patients with endometriosis develop epithelial ovarian carcinoma. The genetic overlap between endometriosis and ovarian cancer has not been fully characterized. This review aims to describe the …
Global epidemiology of ovarian cancer: patterns, trends, and risk factors.
Ovarian cancer was the eighth most frequently diagnosed cancer among women in 2022. The global age-standardized incidence rate of ovarian cancer decreased from 7.22/100,000 to 6.71/100,000 from 1990 to 2021. …